VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 118 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $703,000 | -16.6% | 62,784 | -37.7% | 0.00% | -25.0% |
| Q1 2016 | $843,000 | -10.1% | 100,784 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $938,000 | -17.5% | 100,784 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $1,137,000 | -11.1% | 100,784 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $1,279,000 | +36.5% | 100,784 | 0.0% | 0.01% | +50.0% |
| Q1 2015 | $937,000 | -68.3% | 100,784 | -52.5% | 0.00% | -69.2% |
| Q4 2014 | $2,960,000 | +34.4% | 212,184 | 0.0% | 0.01% | +44.4% |
| Q3 2014 | $2,202,000 | -39.3% | 212,184 | -5.3% | 0.01% | -40.0% |
| Q2 2014 | $3,625,000 | +129.4% | 224,047 | +130.4% | 0.02% | +150.0% |
| Q1 2014 | $1,580,000 | – | 97,226 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |